Additional time enables LAVA Therapeutics (LVTX) to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics and XOMA Royalty anticipate closing the ...
LAVA Therapeutics (LVTX) has decided to cancel the Extraordinary General Meeting of Shareholders scheduled to occur on September 30, 2025 to consider and approve certain matters related to the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results